Free Trial

LENSAR (LNSR) Stock Price, News & Analysis

LENSAR logo
$12.19 -0.40 (-3.18%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$12.20 +0.01 (+0.08%)
As of 08/27/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LENSAR Stock (NASDAQ:LNSR)

Key Stats

Today's Range
$12.19
$12.63
50-Day Range
$12.19
$13.32
52-Week Range
$3.80
$17.31
Volume
60,595 shs
Average Volume
57,760 shs
Market Capitalization
$145.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Consensus Rating
Hold

Company Overview

LENSAR Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

LNSR MarketRank™: 

LENSAR scored higher than 21% of companies evaluated by MarketBeat, and ranked 864th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LENSAR has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    LENSAR has received no research coverage in the past 90 days.

  • Read more about LENSAR's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LENSAR is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LENSAR is -2.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about LENSAR's valuation and earnings.
  • Percentage of Shares Shorted

    5.48% of the float of LENSAR has been sold short.
  • Short Interest Ratio / Days to Cover

    LENSAR has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in LENSAR has recently increased by 2.36%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LENSAR does not currently pay a dividend.

  • Dividend Growth

    LENSAR does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.48% of the float of LENSAR has been sold short.
  • Short Interest Ratio / Days to Cover

    LENSAR has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in LENSAR has recently increased by 2.36%, indicating that investor sentiment is decreasing.
  • News Sentiment

    LENSAR has a news sentiment score of 1.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for LENSAR this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LENSAR insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    38.52% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LENSAR's insider trading history.
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LNSR Stock News Headlines

Lensar (LNSR) Q2 Revenue Rises 10%
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the REAL fortune they expect to come from quantum computing - a $2 trillion explosion by 2035. The kicker? One company is America's FIRST commercial supplier of the material that makes it possible.tc pixel
See More Headlines

LNSR Stock Analysis - Frequently Asked Questions

LENSAR's stock was trading at $8.94 at the beginning of the year. Since then, LNSR shares have increased by 36.4% and is now trading at $12.19.

LENSAR, Inc. (NASDAQ:LNSR) released its quarterly earnings results on Thursday, August, 7th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.08. The company earned $11.36 million during the quarter, compared to analyst estimates of $16.55 million. LENSAR had a negative trailing twelve-month return on equity of 737.30% and a negative net margin of 84.49%.

Top institutional investors of LENSAR include Brandes Investment Partners LP (4.72%), Groupe la Francaise (2.11%), Geode Capital Management LLC (1.86%) and Credit Industriel ET Commercial (1.43%). Insiders that own company stock include Thomas R Staab II and Gary M Winer.
View institutional ownership trends
.

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LENSAR investors own include Arch Capital Group (ACGL), Aprea Therapeutics (APRE), Artelo Biosciences (ARTL), AstraZeneca (AZN), Baidu (BIDU), Cidara Therapeutics (CDTX) and Carlyle Group (CG).

Company Calendar

Last Earnings
8/07/2025
Today
8/28/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LNSR
CIK
1320350
Fax
N/A
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$15.00
Potential Upside/Downside
+23.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.40 million
Net Margins
-84.49%
Pretax Margin
-84.49%
Return on Equity
-737.30%
Return on Assets
-72.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.52
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$53.49 million
Price / Sales
2.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.93) per share
Price / Book
-6.32

Miscellaneous

Outstanding Shares
11,940,000
Free Float
7,338,000
Market Cap
$145.55 million
Optionable
Optionable
Beta
0.50
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:LNSR) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners